Categories
Healthcare Technology

Evolving Leadership in Healthcare: In discussion with Health Tech Leader Ravi Ramaswamy

Healthcare is at the cusp of change. To drive any change, we need an evolution in the way of thinking. This tone has to be set on the top hence we need a change in the thinking of the leaders.

In the first part of the series, I am talking to Health Tech leader Ravi Ramaswamy, CEO of RV Consultants. A veteran of the health tech industry, Ravi has lead global giants like GE Healthcare and Philips to market success. Here are the extracts from the conversation.

Dr Vikram Venkateswaran:  Dear Ravi, thank you for taking time out of your schedule, and talking to me on this very interesting series. So the first question is, you know because you’ve seen it all when you started healthcare was in a different state in the country. Now today we are talking about a lot of big things. Also, you always talk about how it’s an ecosystem play. We should not think in silos; can we work together today you’re trying to bring various parties together right that’s essentially what you’re trying to do. So why do you think that new, new thinking is required on leadership for healthcare today?

Ravi Ramaswamy: Thank you for inviting me and I think this is a very important question. I think we have to look at it from multiple aspects. There is a certain play, which the technology has brought in. There is a certain play, which the players have the providers of healthcare have brought it. There is a certain play which the consumers themselves have brought in, given the fact that the, the consumer centricity has gone quite a bit.

Let’s look at other industries, like telecom, mobile phone and the associated apps have brought in a very different social connect to what is actually happening. People like my mother at 85, she reaches out to her sister for comparing notes on medicines and doctor prescriptions. This is the creation of a healthcare ecosystem of referrals and sharing medical best practices amongst two individuals

So in that sense, what you’re trying to see is the type of a social Connect, which my mother does at 85. I didn’t see when she was maybe at 65, almost 20 years back. She never even wanted a mobile phone even when I offered to buy her one.

But now with the surrounding ecosystem has grown What is it is also putting the sort of pressure on her to try and see how do she be one with the surrounding. So that is one aspect.

So, the impact of a parallel development in another sector is trying to sort of push a certain amount of growth in the healthcare space itself.

Second one is the role of internet itself.

Almost 30 years ago my boss had asked me to check for the end suppliers to one of our suppliers for printer material. I remember going to the US embassy in Delhi and spending hours there looking through the books to see the name of the supplier for the printer material and finally found it. But today it is a click of a button.

So the power of networking the power of Internet has brought to for access to data in a very different form.

Now number three is the technology itself.

The technology is evolved considerably considering where we were to where we are today.

Take the manufacturing space SMT was being introduced, way back in the 1985. In fact, the first time when I saw in 1985 floppy drive in Japan, it was aha for me, because I had never seen that before. It was just about introduced and basically a three-and-a-half-inch drive storing one megabyte of data that was a big deal for us in those days.

But then if you look at what technology has done for us. It has sort of brought in a very different. There is so much of power that is being packed in fact, a simple mobile phone, that is almost as powerful as a supercomputer of what existed in the 80s. So that is the type of compute power that you bring in and along with that, the processing power has gone up, the algorithms are better and the decision support systems that are, that are driven, that has also gone up so technology has also played a substantial role in this evolution.

Number four is the commercial business innovation, people have started coming together they have felt the need that a siloed approach is not going to work. Because as data gains pre-eminence, you find that it is going at some point in time it is going to be device agnostic.

Ravi Ramaswamy , CEO RV Consultants, EX GE Healthcare, EX Philips

Dr Vikram Venkateswaran: Very interesting train of thought- Innovation in other industries, role of internet, technology and commercial business innovation are helping us build this ecosystem in India, but what about this last statement on being device agnostic, can you help me understand that as well?

Ravi Ramaswamy: The device is only going to give you the data the balance of the insights and the interpretation is done by the software piece, and the decision support systems which run well above the devices per se. We have seen significant growth in that space as well. If you look at the industry, healthcare has gone leaps and bounds in terms of its capability in diagnostics and getting into the realm of personalised medicine.

Earlier where they used to go the doctor would say, He will take an X ray of a liver or he will do an ultrasound of a lever, and he will look, do a, a CT of Oliver, but each of these were looked at as independent polarities today what the doctor says is, hey I want to look at it as a whole.

Therefore, give me a technology by which I’m able to fuse all this to reconstruct the liver in its true form, so that I can do a much better diagnosis, and he doesn’t stop there. He says, now what I want to do is to go to a tissue level. I want to go to a molecular level, and I want to go down to a genomic level, to see what is it,

The problem, that you’re trying to fix it at the root itself. So the depth to which medicine has gone is significant. Last but not the least, you find that the competition to the traditional healthcare companies like Siemens or GE or Philips is coming, not from the big guys alone, but also from the unconventional players like the Amazon and the Google and Microsoft, which in the earlier days was simply not there.

Microsoft was never into healthcare; neither was Google into healthcare neither was Amazon into healthcare. They were happy selling their own operating system, Amazon was happy with this bookstore. But, so basically what you see is there is a complete change in the environment. And that has resulted in a very different thinking that is needed in today’s world, which simply did not exist the past. In the past did not need it. today it just needed.

Another good example are the start-ups. Yesterday when he was talking to somebody saying that they are building an app store where medical applications are put on a Play Store. From where you download the application, use it for what you need and then pay it on an asset on a per use basis, without really owning the algorithm per se. So, the business model is also evolved and therefore you find that all the changes that we talked about, you find that the conventional old leadership will simply cannot work in today’s world, and therefore the new, therefore the need for a new world for the, for our leadership in the new world.

Dr Vikram Venkateswaran: There is interesting that you bring up Amazon because today they have invested in Apollo pharmacy, for example, and it is not a new thing for Amazon because they tried pharmacies in the past, during the 90s as well, and did not succeed but now they are back and we all know that Apple as well as Google as, as well as Microsoft is coming into the healthcare space primarily on the basis of data and technology. So, how do you think this new thinking will come in. Do you think it will come from a lot of relearning and learning from the traditional firms? Do you think it will come from the technology firms, or do you think this learning will come from our educational institutions where do you think this this new learning will come from?

Ravi Ramaswamy: Let’s look at the Med tech firms and in particular CT Scans.  Med Tech Firms always priced themselves saying, I am going to bring in a certain amount of capability within the device itself for diagnostics, you started with the 8 slice, then you went for a 16 slice CP then the 32, then a 64, then a 128 and the Toshiba came out the 256 Slice CT.

The same was the case in MRI you started off with the point to Tesla, then you had a one then you had a 1.5 Tesla, then somebody brought in a 3 Tesla and that people are also at some point in time we’re talking about 7 Tesla.

So, technology has also developed. Okay, but at some point in time, you ought to realise saying that it’s like a mobile, it’s like a mobile camera, whether you have anything more than a 10-megapixel camera whether it is 10 or 100, the image resolution that you’re going to see is the same. It doesn’t matter. Beyond that, what’s going to happen is, how am I going to take that 10 or that 100 megapixels and at that point 100 Megapexel can be a pain for you because of the data size that you need to transfer over the network without any added benefits for you.

Going back to the MRI for both applications or 1.5 Tesla is more than enough for you. You don’t require anything more than that. So, given that saturation has started to some point.

The stage is taking the data and interpreting meaningful insights out of it. And that is the job is predominantly done by the doctors. And so now if you have a doctor, who are able to look at this data, and then work with the Amazon and the Microsoft or the Google, who have phenomenal analytical capability in terms of driving analytics deep learning and what have you.

Then where is the need for the med tech companies then. So you will find that at some point in time technology, I can reduce exposure rate as then because the balance of it can be done by the software.

Take for example Phillips’s MRI. On a 3 Tesla machine. It takes about 40 minutes for a head scan for a brain scan. You do one thing you under us under sample that 20 minutes. And the balance of the image reconstruction which is done by the software. So what do you go and claim to the world I am able to do a scan in 20 minutes.

Okay, so the same story, can also be done by the Amazons and the Googles of the world, in conjunction with the clinical knowledge, which the hospital provides. And therefore, you will find that unless the med tech companies themselves don’t keep pace with this sort of AI, Data Science, ML and Deep Learning and what have you, you will find that they will be left behind by the Amazons and the Googles of the world, surely because of the intelligent, the analytical the analytics processing power, that these guys otherwise have.

Dr Vikram Venkateswaran: So the next wave of leadership, you’re saying will mostly either will be technology firms like Google and Amazon or, it also might be traditional healthcare firms trying to react to this new situation and bringing in some leadership in this area?

Ravi Ramaswamy: What I expect to see going forward is issues like interoperability that have always been a question.

Now we might see a situation where even the biggies collaborating between themselves. So then the data becomes portable, otherwise they have a challenge in hand. Okay, so there is going to be a collaboration of sort between the biggies, and it is in their interest that they come up with standardised protocols

And that is because again from the customer perspective, the hospital is still telling the manufacturer that I see guys. I don’t care whether you give me an MRI or a CT, you give me a solution for a care continuum. And the moment that happens, you would want to look for the best in class equipment across the segment.

For all you know it could be a Philips cath lab, it could be a MRI from Siemens and a CT from GE. And when you want to fuse all this. The provider is going to ask for a certain amount of interoperability between these devices otherwise you’re going to put pressure on you saying I don’t need your machine. So, the very fact that the world is now headed towards a solutions play rather than a modality play is also going to put sufficient pressure on the manufacturers from an interoperability perspective, and that once it happens, will also drive data integration data portability and what have you in the future. So, there is a big sequence of events that is being sort of lined up

Dr Vikram Venkateswaran: Now a kind of counter question. Do you see any role for educational institutions in this, even the medical institutions do you see any leadership coming out of them?

Ravi Ramaswamy: Whenever I go to these campuses or wherever I sort of speak to some of these, Vice Chancellors and others a lot of people have asked me saying what are the difference between an American ecosystem and an Indian ecosystem.

One thing for sure, is the amount of interaction that a Stanford has with it’s with the ecosystem of the industry, which includes the payer, the provider and the med tech companies, you don’t get to see that in India.

Number two, the educational institutions they follow a system, or an academic system of SOP, which is more based on creating papers. Whereas, the, the latest and greatest of what the industry needs are, is never thought. And that’s possibly the reason when a new graduate joins the industry, It takes about nine months for him to even get his hands and feet wet. So from that perspective, one piece of advice that I’ve been giving these institutions is keep tab on what the industry needs are and try and see how you can build your syllabus to address that need so that when the student leaves the college he hits the ground and starts running.

Take for example security, privacy. How many of the colonists teach that year, there is hardly any, you can count.

Take Intellectual Property (IP), for example, how many people. How many colleges have even a course on IP, or even bring in a certain representation as to what an IP is intellectual property is all about data even more serious quality and regulatory hyperreal medical industry is a hyper regulated industry.

When I talk about the CDC, and FDA people turn around and ask what’s the full form. Now, that that ought to be and therefore, there is a certain amount of leadership that the educational institutions have to deliver.

There was one incident I remember when I was talking about MRI and CT, one of the professors came to me and asked me the difference between them. Now the professor himself has not seen one. So what do you expect the professor to teach the students on. So there ought to be a certain amount of sabbatical for the professor to come in, spend time in the medtech world, so that he is able to understand what the industry is heading towards he gets to absorb that portion of it so that he can go and impart it to his students. I think you really need to change the education as well.

Dr Vikram Venkateswaran: Very fascinating and great insights, then one last question what does the future healthcare leader look like, like what are the attributes he or she should have?

Ravi Ramaswamy: I see the future leader of healthcare as an interdisciplinary person who is adept in technology, as much as much as commercial innovation. He ought to be sort of embracing the start-up ecosystem and not believe on the fact that everything needs to be done in house. So, it ought to be a lot more collaborative with the ecosystem. You need to understand. You need to understand the fact that the competition for you is not coming from the traditional players but from the sort of niche and focused technology companies, and therefore we adapt and hands on in terms of playing around with technology.

So the era of people managers in healthcare is over we would need but more like a techno functional leader who is able to sort of roll, roll up his sleeves and get into the depth of it, to understand what the hell is going on, and at the same time be savvy, be smart enough to understand that certain commercial innovations have to be baked into the design process itself as it is never going to hit the road. So you need to have a well-rounded personality, and it’s going to be. It’s going to be very different than the traditional people managers whom you have seen are just sort of one functional expert coming to the top, I think that won’t work anymore.

Dr. Vikram Venkateswaran: Dear Ravi Thank you for your time

Categories
Healthcare Technology

Blockchain in Healthcare

Last week I participated in the Virtual Blockchain in Healthcare Symposium. The #VBIHS2020 is to be a platform where people related to the healthcare industry can gain in-depth knowledge on how blockchain can leverage the healthcare industry in present & future pandemics. It also convenes the necessary resources to drive systemic transformation and unleash the full potential of blockchain in the healthcare industry.

Healthcare India was a partner to the event, this really helped us build on the work we had already done in the past. In 2018 we had produced a paper on Blockchain, on how it could change healthcare in India. Two years hence not much has happened.

I shared the panel with eminent healthcare leaders from the Middle East and was able to exchange ideas on how to enable blockchain adoption in Asia and in the world.

Below are the key points on the same

  • Business Case- Dr Mussaad brought up ABC in healthcare technology

A- Analytics

B- Blockchain

C- Cloud

While Analytics and Cloud have taken off, Blockchain has been left behind. And I think the primary reason for that is the lack of a good business case. Blockchain has still not left the CTO office and the adoption from a commercial technology point of view is still pending.

  • Government Standards- I still don’t see any standards from the government. In India, while there are standards for AI and ML bit still nothing for Blockchain. That needs to change. Government has to set the bar, while they have introduced Sand Boxes, it needs to go beyond that.
  • Lastly need for talent, there is no talent available in the market to implement Blockchain. this is a key component to the growth. While educators have talked about it pretty openly but little action has been taken on the ground.

But would love to hear your views as well.

Categories
Healthcare Technology

The Virtual Blockchain in Healthcare Summit

Blockchain in healthcare has been an area of immense interest to me. I believe that a system of records available real-time would solve a lot of the issues that we see in healthcare today. As part of my efforts to build consensus and understand how Blockchain can solve some of the issues in the healthcare ecosystem, I regularly connect with healthcare leaders through events, conferences, and forums. 

Virtual Blockchain in Healthcare Symposium #VBIHS2020 is poised to be a platform where people related to the healthcare industry can gain in-depth knowledge on how blockchain can leverage the healthcare industry in present & future pandemics. It also convenes the necessary resources to drive systemic transformation and unleash the full potential of blockchain in the healthcare industry.

I am anticipating meeting around 10-15 healthcare leaders as part of the event, interacting across 4 sessions and ability to talk to more than 20 solution providers and influencers. 

I am speaking on a panel on Healthcare ecosystem and how it can leverage Blockchain, but the other topics being discussed include 

–          Blockchain & Artificial intelligence,

–          E-Health & M-Health

–          Healthcare Data Exchange

–          Pharma Supply chain

–          Blockchain Applications

Below are some additional links for the event and I’m looking forward to meeting you all there.

Social Media Links,

Event Register Link: http://www.blockchaininhealthcare.net/register.php

Categories
Healthcare Technology

Blockchain in Healthcare

Healthcare today has been adopting new technology like never before. As a result of this we have many significant developments in recent days. Let’s take for instance the adoption of telemedicine by both patients and care providers alike during the Covid 19 pandemic. It is significant to note how quickly the ecosystem moved ahead and adopted the new standards and today we have multiple consultations on telemedicine.

Similarly, the development of the Covid19 vaccine has been possible partially due to the increased collaboration between the scientific community made possible by digital technologies.

Blockchain has become a game changer in the healthcare industry. It is a foundational technology with capabilities that go way beyond the traditional IT stack. With features like immutability, digital identity, encryption and real time updates, Blockchain has many of the features that would help the industry evolve to the next level. 

Last year Priyank Jani and I wrote a paper on Blockchain where we discussed how it could be implemented in the healthcare industry. Here is the link of the paper. 

But before we go forward let me quickly discuss what is Blockchain. 

Blockchain is a continuously growing list of records, called blocks, which are linked and secured using cryptography.  Each block contains, typically, a link to a previous block, a timestamp and transaction data. Transactions have to be approved by all users of the Blockchain to be stored and modifying an older block of data is impossible. Only updating of future records is permissible making the system secure (relatively speaking) and therefore reliable. This also means an entire Blockchain can serve as a secure ledger that records transactions, negating the need for multiple disparate trails of information.

We believe Indian healthcare has most to gain from the adoption of Blockchain technology. For starters, Blockchain allows all types of data to be integrated into the chain. This means one can add not just doctor prescriptions and treatment records but also nutrition information, fitness data, and recordings from medical devices (such as for blood pressure and diabetes patients) by patients themselves. Over time the presence of such longitudinal patient data means caregivers can better interpret disease symptoms and prescribe effective treatment that is customized to work for the patient. Currently, doctors rely on data from treating different patients to prescribe medication. The chances of success for such medication are about 50%. In many cases, doctors wait for feedback from patients to change the medication. With the availability of longitudinal patient data, doctors would know in advance what treatments are more likely to suit a patient in line with his/her health history.

If implemented over a large scale, Blockchain could help significantly lower healthcare costs in India. In addition, it can give multiple parties selective access to patient records ensuring data is not compromised. A survey report by IBM outlines the following healthcare areas benefiting from Blockchain: clinical trial records, patient health records, regulatory compliance, medical device data integration, treatment records, billing and claims, asset management (for hospital assets such as beds/ equipment available), and contract management (for hospitals).

I am really looking forward to the virtual Blockchain summit that is taking place on the 9h of December 2020. I plan to discuss with the various global leaders how Blockchain can be incorporated into the healthcare ecosystem. Do register if you are interested in discussing Blockchain and building a consensus in this area. The link for registration is here- Register | BlockChain in HealthCare

Categories
Healthcare Technology

TataMD Check launched for Covid19 testing

Tata Medical and Diagnostics Ltd (TataMD), the healthcare venture from Tata Group has launched the Tata MD check, which is probably India’s first and probably the largest COVID19 diagnostic kit. This kit has been built in association with CSIR- IGIB and is built on top of a CRISPR Cas 9 for COVID19 testing. The algorithm, incidentally, is called Feluda. Very interesting to note that it might be in reference to the detective character created by Satyajit Ray.

It took about 100 days for Tata MD,for its licencing and commercial launch. And also, it has been approved by the Indian Council of Medical Research (ICMR) and the DGCI and will be available through our diagnostic centres in India. It’s a paper based test with the image based visual readout. The reaction time is about 45 minutes, and the total testing time is about 75 minutes only because it’s from an mRNA extracted sample. There is high scalability. About 1 million of these test kits will be produced in a month from the Tata diagnostic and Research Centre outside of Chennai in Tamil Nadu.

Also, there is an AI based reporting tool that will help authorities keep track of traceability of samples and the results will be accessible from anywhere. And it. This test will allow from and massive rapid adoption potential to the far away regions of the country. It will be interesting to see how this pans out considering the seem to be close to good testing we seem to be close to a good vaccine and we seem to be good, close to a good protocol. Let’s see how things go from here.